IBDoc Canadian User Performance Evaluation
Alice Moore(University of British Columbia), Greg Rosenfeld(British Columbia Centre on Substance Use), Yvette Leung(University of Calgary), Raymond Bourdages(Centre intégré de santé et de services sociaux de Chaudière-Appalaches), Brian Bressler(University of British Columbia), Vivian Huang, Christian Reinhard(Bühlmann (Switzerland)), Richard N. Fedorak(University of Alberta)
Cited by 10
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
|Gastroenterology|2008|750
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478